Case Overview: The FTC has filed a contempt motion against dietary supplement company Amare Global and three individuals, alleging they violated an existing federal court order by continuing to make unsubstantiated health claims about their products.

Consumers Affected: Parents and other consumers who purchased Amare Global dietary supplements marketed for children and adults, as well as individuals recruited as "brand partners"

Court: Federal court (district not specified in source)

Latest Development: FTC contempt motion filed against Amare Global, former Chief Science Officer Shawn Talbott, and two additional individuals

FTC Seeks Contempt Finding Against Amare Global Over Continued Unsubstantiated Health Claims

The Federal Trade Commission has escalated its legal action against dietary supplement company Amare Global Holdings, asking a federal court to hold the company and three individuals in contempt for allegedly violating an existing FTC order — one that had already banned certain individuals from making false or unsubstantiated health claims.

According to an FTC press release announcing the contempt motion, the agency alleges that Amare Global, former Chief Science Officer Shawn Talbott, founding brand partner Patrick Hintze, and current CEO and majority shareholder David Chung violated the prior order by continuing to make deceptive and unsubstantiated claims about their supplement products.

What the FTC Alleges

The contempt motion centers on alleged violations of an earlier FTC order that specifically prohibited Talbott — and those working with him — from making false, deceptive, or unsubstantiated health claims.

The FTC's filing alleges that the defendants did not comply with those restrictions. According to the agency, Amare Global's marketing allegedly represented to parents and consumers that its dietary supplements — including products marketed for children — could treat, cure, or mitigate serious health conditions including depression, anxiety, and ADHD.

The agency's position is that those claims lacked adequate substantiation, in apparent violation of the existing court order.

Background: A Second Front in Ongoing FTC Action

The contempt motion follows separate litigation the FTC initiated earlier in June 2026. In that action, the agency sued Amare Global, Talbott, Hintze, and Chung, alleging the company misrepresented the health benefits of its supplement products to consumers and made misleading income claims to individuals it recruited as "brand partners" — independent sellers within the company's multilevel marketing structure.

That lawsuit alleged that Amare Global marketed supplements with claims suggesting they could address conditions like depression, anxiety, and ADHD, without the clinical evidence required to support such representations. The FTC also alleged the company misled prospective brand partners about the income they could realistically expect to earn by selling its products.

The contempt motion represents a parallel enforcement track — one that could carry additional legal consequences for defendants who were already subject to a prior federal order.

What This Means for Consumers

The FTC's contempt filing signals that the agency believes Amare Global and its leadership continued problematic marketing practices even after being subject to prior legal restrictions. If the court agrees, the defendants could face sanctions beyond those sought in the underlying lawsuit.

For consumers who purchased Amare Global products based on health claims — particularly parents who bought supplements marketed for children's mental health conditions — the agency's allegations raise questions about whether those claims were supported by credible scientific evidence.

The FTC's action also touches on income representations made to brand partners, individuals who may have invested time and money into building a sales business based on what the agency alleges were misleading earnings projections.

What Comes Next

The federal court will need to determine whether Amare Global and the named individuals violated the prior order — the threshold question for any contempt finding. That proceeding will run alongside the FTC's separately filed lawsuit challenging the company's marketing and recruitment practices.

No trial date has been publicly announced at this stage. The litigation and contempt proceedings remain ongoing.

Parties: FTC v. Amare Global Holdings, Shawn Talbott, Patrick Hintze, David Chung

Court: Federal court (district not specified)

Status: Contempt motion filed; parallel FTC lawsuit also pending as of June 2026

Have you or a family member purchased Amare Global dietary supplements based on health claims? Legal options may be available — consider speaking with a qualified attorney to understand your rights.